ScholarLens Back to search
2010•Unpublished venueRequires access

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DROTAVERINE HYDROCHLORIDE AND ACECLOFENAC IN TABLET DOSAGE FORM BY RP-HPLC

Santosh Vilashchand Gandhi, Padmanabh B. Deshpande, Vivek S Rajmane, Tanmay Dodal, Jitesh Parab

Open publisher page 3 citations

Abstract

A simple, accurate, sensitive and validated RP-HPLC method for simultaneous determination of Drotaverine hydrochloride and Aceclofenac in combined tablet dosage form has been developed. Separation was carried out on Jasco HPLC system equipped with Hypersil GOLD C18 column (250 x 4.6 mm i.d.) and UV/VIS detector using Methanol: 10 mM potassium dihydrogen phosphate buffer in ratio of (80:20, v/v) as mobile phase and detection was carried out at 231 nm. Ambient temperature conditions were maintained. Results were linear in the range of 4-20 µg/ml for Drotaverine hydrochloride and 4-24 µg/ml for Aceclofenac. The method has been successfully applied for the analysis of drugs in pharmaceutical formulation. Results of analysis were validated statistically and by recovery studies.

About this research paper

What this paper is about

A simple, accurate, sensitive and validated RP-HPLC method for simultaneous determination of Drotaverine hydrochloride and Aceclofenac in combined tablet dosage form has been developed. Separation was carried out on Jasco HPLC system equipped with Hypersil GOLD C18 column (250 x 4.6 mm i.d.) and UV/VIS detector using Methanol: 10 mM potassium dihydrogen phosphate buffer in ratio of (80:20, v/v) as mobile phase and detection was carried out at 231 nm. Ambient temperature conditions were maintained. Results were linear in the range of 4-20 µg/ml for Drotaverine hydrochloride and 4-24 µg/ml for Aceclofenac. The method has been successfully applied for the analysis of drugs in pharmaceutical formulation. Results of analysis were validated statistically and by recovery studies.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A simple, accurate, sensitive and validated RP-HPLC method for simultaneous determination of Drotaverine hydrochloride and Aceclofenac in combined tablet dosage form has been developed. Separation was carried out on Jasco HPLC system equipped with Hypersil GOLD C18 column (250 x 4.6 mm i.d.) and UV/VIS detector using Methanol: 10 mM potassium dihydrogen phosphate buffer in ratio of (80:20, v/v) as mobile phase and detection was carried out at 231 nm. Ambient temperature conditions were maintained. Results were linear in the range of 4-20 µg/ml for Drotaverine hydrochloride and 4-24 µg/ml for Aceclofenac. The method has been successfully applied for the analysis of drugs in pharmaceutical formulation. Results of analysis were validated statistically and by recovery studies.

Key concepts: Aceclofenac, Chromatography, Dosage form, High-performance liquid chromatography, Chemistry, Potassium, Methanol, Organic chemistry

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DROTAVERINE HYDROCHLORIDE AND ACECLOFENAC IN TABLET DOSAGE FORM BY RP-HPLC — Research Paper | ScholarLens